Quantum eMotion Corp. announced a broad commercial and technical Agreement with Greybox Solutions, of Montreal. This partnership will enable Greybox's
Digital Therapeutic product to take advantage of QeM's Quantum-Safe cryptographic platform. Digital Therapeutics refers to the use of technology-driven solutions, such as mobile apps, wearable devices, and telemedicine, to deliver evidence-based interventions for the prevention, management, and treatment of various medical conditions. It aims to enhance patient outcomes by leveraging the benefits of technology such as patient health records convenience, accessibility, and real-time monitoring and feedback. Strong Cybersecurity protection is crucial in Digital Therapeutics as cybercriminals often consider patient health records as one of their main targets. According to various reports, data breaches affecting the healthcare industry have been on the rise in recent years, and millions of patient records have been compromised. The impact of these breaches can be severe, both for the individuals whose personal and sensitive information has been stolen, as well as for the organizations responsible for securing that data. Digital Therapeutics is the corner stone of the telemedicine market that is rapidly growing due to the increasing adoption of virtual healthcare solutions amid the COVID-19 pandemic. The market is expected to reach USD 191.9 billion by 2026, growing at a CAGR of 18.0% from 2020 to 2026. Factors driving growth include the increasing use of telemedicine for remote patient monitoring, growing demand for home healthcare, and advancements in technology. The agreement establishes QeM as Greybox's cybersecurity partner and this collaboration will integrate and promote QeM's cybersecurity technology with Greybox's TakeCareTM product, helping health professionals and patients manage their treatment plan at home to reduce hospital readmissions and improve health outcomes.